# Bioequivalence of a Single Subcutaneous Dose of Epoetin Beta in Healthy Japanese and Caucasian Male Subjects

> **NCT01085552** · PHASE1 · COMPLETED · sponsor: **InCROM Europe Clinical Research** · enrollment: 23 (actual)

## Conditions studied

- Chronic Kidney Failure
- Anaemia

## Interventions

- **DRUG:** Epoetin Beta

## Key facts

- **NCT ID:** NCT01085552
- **Lead sponsor:** InCROM Europe Clinical Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2008-10
- **Final completion:** 2008-10
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2010-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01085552

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01085552, "Bioequivalence of a Single Subcutaneous Dose of Epoetin Beta in Healthy Japanese and Caucasian Male Subjects". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01085552. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*